Vivimed Labs Limited: No physical share transfer requests re-lodged in June 2026
Vivimed Labs Limited reported no activity regarding the re-lodgement of physical share transfer requests in June 2026. The company's Registrar and Share Transfer Agent confirmed zero requests received, processed, approved, or rejected during the month, as per SEBI guidelines.
This is a routine regulatory filing with no material impact on the company's operations or financial performance.
The announcement is a routine update regarding share transfer requests and does not contain any positive or negative financial or business developments.
Vivimed Labs Limited has provided an update regarding the re-lodgement of transfer requests for physical shares. In compliance with SEBI Circular No. SEBI/HO/38/13/11(2)2026-MIRSD-POD/ 1/3750/2026 dated January 30, 2026, the company received reports from its Registrar and Share Transfer Agent, Aarthi Consultants Private Limited.
As per the report dated July 06, 2026, concerning the status as of June 2026, Aarthi Consultants Pyt Ltd confirmed that there were no requests received, processed, approved, or rejected during the month for the re-lodgement of transfer requests of physical shares under the special window provided by SEBI. Consequently, the average time taken for processing requests was not applicable (NA).
This information is for the information and records of the stock exchanges.
What to do with a filing like this
Vivimed Labs Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Vivimed Labs Limited. Read the original for the full detail.